Yousef N Alhashem

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 24

Top Topics

Prostate Cancer

Artificial Intelligence

Respiratory Syndrome Coronavirus

Top Venues

Current oncology (Toronto, Ont.)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Roua A Alsubki, Jawaher M Al-Otaibi, Yousef N Alhashem, Neda A Alali, Tarek Sulaiman, Zainab Alsalem, Huda A Bajunaid, Mohammed Garout, Heba A Alsaffar, Souad A Almuthree, Doha Hudhaiah, Azhar M Alzaher, Fatimah A Alshaikh, Amer Mohammad Alshengeti, Mustafa A Najim, Ramadan Abdelmoez Farahat, Ranjan K Mohapatra
Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Microorganisms 11 (2) (2023)
Ali A Rabaan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Roua A Alsubki, Jawaher M Al-Otaibi, Yousef N Alhashem, Neda A Alali, Tarek Sulaiman, Zainab Alsalem, Huda A Bajunaid, Mohammed Garout, Heba A Alsaffar, Souad A Almuthree, Doha Hudhaiah, Azhar M Alzaher, Fatimah A Alshaikh, Amer Mohammad Alshengeti, Mustafa A Najim, Ramadan Abdelmoez Farahat, Ranjan K Mohapatra
Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Microorganisms 11 (2) (2023)
Ali A Rabaan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Roua A Alsubki, Jawaher M Al-Otaibi, Yousef N Alhashem, Neda A Alali, Tarek Sulaiman, Zainab Alsalem, Huda A Bajunaid, Mohammed Garout, Heba A Alsaffar, Souad A Almuthree, Doha Hudhaiah, Azhar M Alzaher, Fatimah A Alshaikh, Amer Mohammad Alshengeti, Mustafa A Najim, Ramadan Abdelmoez Farahat, Ranjan K Mohapatra
Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Microorganisms 11 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Roua A Alsubki, Jawaher M Al-Otaibi, Yousef N Alhashem, Neda A Alali, Tarek Sulaiman, Zainab Alsalem, Huda A Bajunaid, Mohammed Garout, Heba A Alsaffar, Souad A Almuthree, Doha Hudhaiah, Azhar M Alzaher, Fatimah A Alshaikh, Amer Mohammad Alshengeti, Mustafa A Najim, Ramadan Abdelmoez Farahat, Ranjan K Mohapatra
Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Microorganisms 11 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Muhammad Naveed, Allah Rakha Yaseen, Hira Khalid, Urooj Ali, Ali A Rabaan, Mohamed Garout, Muhammad A Halwani, Abbas Al Mutair, Saad Alhumaid, Zainab Al Alawi, Yousef N Alhashem, Naveed Ahmed, Chan Yean Yean
Execution and Design of an Anti HPIV-1 Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses: An Immunoinformatic Approach. Vaccines 10 (6) (2022)
Muhammad Zeeshan Ali, Arshad Farid, Safeer Ahmad, Muhammad Muzammal, Mohammad Al Mohaini, Abdulkhaliq J Alsalman, Maitham A Al Hawaj, Yousef N Alhashem, Abdulmonem A Alsaleh, Eman M Almusalami, Mahpara Maryam, Muzammil Ahmad Khan
In Silico Analysis Identified Putative Pathogenic Missense nsSNPs in Human SLITRK1 Gene. Genes 13 (4) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Abbas Al Mutair, Saad Alhumaid, Jumana M Al-Jishi, Jehad AlSihati, Hawra Albayat, Ahmed Alsheheri, Mohammed Mubarak Aljeldah, Mohammed Garout, Wadha A Alfouzan, Yousef N Alhashem, Salma AlBahrani, Saleh A Alshamrani, Sultan Alotaibi, Abdullah A AlRamadhan, Hanadi N Albasha, Khalid Hajissa, Mohammad-Hani Temsah
Systematic Review on Pathophysiological Complications in Severe COVID-19 among the Non-Vaccinated and Vaccinated Population. Vaccines 10 (7) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Azka Rizvi, Muhammad Umer Saeed, Ayesha Nadeem, Asma Yaqoob, Ali A Rabaan, Muhammed A Bakhrebah, Abbas Al Mutair, Saad Alhumaid, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Hawra Albayat, Ameen S S Alwashmi, Firzan Nainu, Yousef N Alhashem, Muhammad Naveed, Naveed Ahmed
Evaluation of Bi-Lateral Co-Infections and Antibiotic Resistance Rates among COVID-19 Patients in Lahore, Pakistan. Medicina (Kaunas, Lithuania) 58 (7) (2022)
Abdul Shakur Khan, Kifayat Ullah Shah, Mohammad Al Mohaini, Abdulkhaliq J Alsalman, Maitham A Al Hawaj, Yousef N Alhashem, Shakira Ghazanfar, Kamran Ahmad Khan, Zahid Rasul Niazi, Arshad Farid
Tacrolimus-Loaded Solid Lipid Nanoparticle Gel: Formulation Development and In Vitro Assessment for Topical Applications. Gels (Basel, Switzerland) 8 (2) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Muhammad Rehan Malik, Fatemah Farraj Al-Harbi, Asif Nawaz, Adnan Amin, Arshad Farid, Mohammad Al Mohaini, Abdulkhaliq J Alsalman, Maitham A Al Hawaj, Yousef N Alhashem
Formulation and Characterization of Chitosan-Decorated Multiple Nanoemulsion for Topical Delivery In Vitro and Ex Vivo. Molecules (Basel, Switzerland) 27 (10) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Muhammad Muzammal, Alessandro di Cerbo, Eman M Almusalami, Arshad Farid, Muzammil Ahmad Khan, Shakira Ghazanfar, Mohammad Al Mohaini, Abdulkhaliq J Alsalman, Yousef N Alhashem, Maitham A Al Hawaj, Abdulmonem A Alsaleh
In Silico Analysis of the L-2-Hydroxyglutarate Dehydrogenase Gene Mutations and Their Biological Impact on Disease Etiology. Genes 13 (4) (2022)
Muhammad Shahid Latif, Fatemah F Al-Harbi, Asif Nawaz, Sheikh Abdur Rashid, Arshad Farid, Mohammad Al Mohaini, Abdulkhaliq J Alsalman, Maitham A Al Hawaj, Yousef N Alhashem
Formulation and Evaluation of Hydrophilic Polymer Based Methotrexate Patches: In Vitro and In Vivo Characterization. Polymers 14 (7) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Hajir A Al Saihati, Saad Alhumaid, Roua A Alsubki, Safaa A Turkistani, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Ahlam A Alqatari, Hejji E Alahmed, Dalal A Sharbini, Arwa F Alahmadi, Fatimah Alsalman, Ahmed Alsayyah, Abbas Al Mutair
Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer. Cancers 14 (22) (2022)
Ali A Rabaan, Saad Alhumaid, Abbas Al Mutair, Mohammed Garout, Yem Abulhamayel, Muhammad A Halwani, Jeehan H Alestad, Ali Al Bshabshe, Tarek Sulaiman, Meshal K AlFonaisan, Tariq Almusawi, Hawra Albayat, Mohammed Alsaeed, Mubarak Alfaresi, Sultan Alotaibi, Yousef N Alhashem, Mohammad-Hani Temsah, Urooj Ali, Naveed Ahmed
Application of Artificial Intelligence in Combating High Antimicrobial Resistance Rates. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)